Influence of the first wave of COVID-19 on asthma inhaler prescriptions

Abstract In the beginning of the COVID-19 pandemic, there were major concerns regarding the huge demand for asthma inhalers. Using the primary-care medical records for 614,700 asthma patients between January and June 2020, we found that there was a substantial increase in inhalers solely in March 20...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	C. I. Bloom, E. Wong, K. Hickman, S. Elkin
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Diseases of the respiratory system RC705-779
Acceso en línea:	https://doaj.org/article/99c9f829409e414997ec3099d23cce9c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:99c9f829409e414997ec3099d23cce9c
record_format	dspace
spelling	oai:doaj.org-article:99c9f829409e414997ec3099d23cce9c2021-11-28T12:07:15ZInfluence of the first wave of COVID-19 on asthma inhaler prescriptions10.1038/s41533-021-00260-w2055-1010https://doaj.org/article/99c9f829409e414997ec3099d23cce9c2021-11-01T00:00:00Zhttps://doi.org/10.1038/s41533-021-00260-whttps://doaj.org/toc/2055-1010Abstract In the beginning of the COVID-19 pandemic, there were major concerns regarding the huge demand for asthma inhalers. Using the primary-care medical records for 614,700 asthma patients between January and June 2020, we found that there was a substantial increase in inhalers solely in March 2020. Patients significantly associated with receiving higher inhaled corticosteroid prescriptions were younger, of higher socioeconomic status, and had milder asthma.C. I. BloomE. WongK. HickmanS. ElkinNature PortfolioarticleDiseases of the respiratory systemRC705-779ENnpj Primary Care Respiratory Medicine, Vol 31, Iss 1, Pp 1-3 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the respiratory system RC705-779
spellingShingle	Diseases of the respiratory system RC705-779 C. I. Bloom E. Wong K. Hickman S. Elkin Influence of the first wave of COVID-19 on asthma inhaler prescriptions
description	Abstract In the beginning of the COVID-19 pandemic, there were major concerns regarding the huge demand for asthma inhalers. Using the primary-care medical records for 614,700 asthma patients between January and June 2020, we found that there was a substantial increase in inhalers solely in March 2020. Patients significantly associated with receiving higher inhaled corticosteroid prescriptions were younger, of higher socioeconomic status, and had milder asthma.
format	article
author	C. I. Bloom E. Wong K. Hickman S. Elkin
author_facet	C. I. Bloom E. Wong K. Hickman S. Elkin
author_sort	C. I. Bloom
title	Influence of the first wave of COVID-19 on asthma inhaler prescriptions
title_short	Influence of the first wave of COVID-19 on asthma inhaler prescriptions
title_full	Influence of the first wave of COVID-19 on asthma inhaler prescriptions
title_fullStr	Influence of the first wave of COVID-19 on asthma inhaler prescriptions
title_full_unstemmed	Influence of the first wave of COVID-19 on asthma inhaler prescriptions
title_sort	influence of the first wave of covid-19 on asthma inhaler prescriptions
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/99c9f829409e414997ec3099d23cce9c
work_keys_str_mv	AT cibloom influenceofthefirstwaveofcovid19onasthmainhalerprescriptions AT ewong influenceofthefirstwaveofcovid19onasthmainhalerprescriptions AT khickman influenceofthefirstwaveofcovid19onasthmainhalerprescriptions AT selkin influenceofthefirstwaveofcovid19onasthmainhalerprescriptions
_version_	1718408214747283456

Influence of the first wave of COVID-19 on asthma inhaler prescriptions

Ejemplares similares